Addex Therapeutics Ltd (ADXN) Annual Income Statement (USD)
ADXN Quarterly Financials (USD)
Frequently Asked Questions About Addex Therapeutics Ltd (ADXN) Stock
Addex Therapeutics Ltd's (ADXN) last reported annual revenue was USD 1.61 Million.
Addex Therapeutics Ltd's (ADXN) annual revenue growth rate based on the revenue reported in the past 5 years is : -10.20%
Addex Therapeutics Ltd's(ADXN) is not profitable as of its last reported annual financials.
The net profit margin for Addex Therapeutics Ltd's(ADXN) from its laster reported year is -654.47%
The return on equity (ROE) for Addex Therapeutics Ltd's(ADXN) from its last reported annual financials is : -126.29%
The return on assets (ROA) for Addex Therapeutics Ltd's(ADXN) from its last reported annual financials is : -61.71%
The return on invested capital (ROIC) for Addex Therapeutics Ltd's(ADXN) from its last reported annual financials is : -340.12%
The Debt to Equity ratio for Addex Therapeutics Ltd's(ADXN) from its last reported annual financials is : 0.00%
The dividend yield for Addex Therapeutics Ltd's(ADXN) from its laster reported year is 0.00%
Addex Therapeutics Ltd's(ADXN) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Negative earnings
The company had negative total earnings in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ADXN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
